Successful Pharma CMO Summit Co-Hosted by Serialization Expert Supply Chain Wizard and Medicines for Europe Lisbon Summit Forged New Partnerships as U.S. and European Pharma CMOs, CPOs & 3PLs Shared Strategies for Serialization Compliance and Optimized Post-Implementation Operations
Princeton, NJ – Supply Chain Wizard – a leading full-service global consulting firm specializing in serialization and traceability, as well as supply chain strategy and operational transformation programs – and Medicines for Europe, an organization serving as the voice of Europe’s generic, biosimilar and value-added medicines industries, co-hosted their latest Pharma CMO Summit on June 14 in Lisbon, Portugal.
The gathering brought together manufacturers, CMOs, CPOs, 3PLs and solution providers for education and interactive activities centered on serialization compliance, serialized operations and value beyond compliance – and presented a unique opportunity for pharmaceutical industry partners to make or finalize strategies for both initial compliance and optimized post-implementation operations. One of the Summit’s main goals was facilitating conversation between European pharma executives and U.S. industry experts who, in order to comply with the USA’s looming November 2017 deadline, have already prepared themselves for unit-level serialization.
With more than 80 attendees, the Lisbon event featured a variety of keynote presentations on the state of the industry, with experts sharing best practices for launching and managing serialization programs with customers and suppliers, as well as optimizing CMO-customer IT connectivity. Detailed case studies illustrated strategies that have worked best and pitfalls that can be circumvented, and roundtable discussions focused on beyond-compliance value that production digitization can bring to manufacturing operations. Finally, the event featured more than 100 speed-dating sessions providing succinct networking opportunities between vendors, CMOs, 3PLs and pharma manufacturers.
Attendees represented a broad spectrum of functional areas within their respective organizations, and were split into a relatively equal division of executives (46%) and management (44%). The resulting partnership potential was both welcome and well-received.
“Like its successful predecessors, the Lisbon Pharma CMO Summit brought together the full spectrum of supply chain partners,” said Evren Ozkaya, CEO of Supply Chain Wizard. “Networking exchanges were plentiful, and yielded opportunities for partnerships, collaborations and improved business practices moving beyond the need to meet regulatory requirements, into the realm of creating smarter manufacturing and supply chain operations.”
###
About Supply Chain Wizard
Supply Chain Wizard, LLC, is a leading full-service global consulting firm specializing in serialization and traceability, as well as supply chain strategy and operational transformation programs. Dedicated to optimizing operations for growth, service and efficiency, Supply Chain Wizard offers strategic innovations in products and services targeting serialization and supply chain transformation initiatives, along with a team of expert consultants providing comprehensive support toward cost-effective compliance with serialization mandates and post-go-live operational support.
Supply Chain Wizard organizes serialization roundtables, summits and training programs throughout Europe, Asia Pacific and the United States, and runs frequent webinars to support clients with their regulatory and compliance challenges. Committed to helping clients maintain significant and sustainable performance improvements, Supply Chain Wizard guides customers to a more secure supply chain via the implementation of high return-on-investment initiatives. Supply Chain Wizard is headquartered in Princeton, NJ, with additional offices in Germany, Turkey, The Netherlands, the UK and India. For more information, please visit www.supplychainwizard.com.
About Medicines for Europe
Medicines for Europe represents the pharmaceutical companies supplying the largest share of medicines across Europe, and is the voice of the generic, biosimilar and value added industries. As a leading partner for better healthcare, the organization aims to increase the health and wellbeing of all Europeans through better access to high quality medicines. Medicines for Europe members’ portfolio cover 80% of therapy areas, and in so doing, safeguards the sustainability of Europe’s healthcare systems for future generations.
For more information, visit www.medicinesforeurope.com.
